2024-10-24T07:38:22-07:00 2023-12-31 472370837 Artesian CPA LLC 4915 Easley Rd Golden CO 80403 990 2023-01-01 472330752 COLORADO DIGITAL HEALTH COLO 5154477054 303 E 17TH AVE DENVER CO 80203 SARAH LAMPE PRESIDENT & CEO 5154477054 2024-05-07 true true CRAIG DENLINGER P01063062 3038233220 2024-05-28 2023 2024-10-15 13:58:12Z PRIME HEALTH SARAH LAMPE 303 E 17TH AVE STE 405 DENVER CO 80203 1003291 false X WWW.PRIMEHEALTHCO.COM X 2015 CO PRIME HEALTH ADVANCES HEALTH JUSTICE, EQUITY, ACCESS QUALITY AND COST THROUGH INNOVATION, COLLABORATION, AND COMMUNITY BUILDING. 9 9 7 9 0 0 695500 822017 378441 180798 130 476 8750 0 1082821 1003291 0 0 528814 525044 0 85534 414010 620766 942824 1145810 139997 -142519 814405 724865 241586 300864 572819 424001 PRIME HEALTH ADVANCES HEALTH JUSTICE, EQUITY, ACCESS QUALITY AND COST THROUGH INNOVATION, COLLABORATION, AND COMMUNITY BUILDING. false false 919859 0 180798 WE CONVENE STAKEHOLDERS FROM DIVERSE INDUSTRIES, ORGANIZATIONS, BACKGROUNDS AND PERSPECTIVES TO BUILD COMMUNITY, CONSENSUS, COORDINATION AND CAPABILITIES AS A MEANS TO SOLVE PROBLEMS BY CATALYZING INNOVATION, IMPLEMENTING PILOT PROGRAMS, AND ACCELERATING SUSTAINABLE HEALTH CARE REFORM. 919859 true true false false false false false false false false true false false false false false true false false false false false false false false false false false false true false false false false false false false false false false false false false false false false false true 4 0 7 true false false false false false false false false false false X 9 9 false false false false false false false true true false false true false false false true true false SARAH LAMPE 3039976827 303 E 17TH AVE STE 405 DENVER CO 80203 RACHEL DIXON FORMER PRESIDENT & EXECUTIVE DIRECTOR 40.00 X X X 143739 0 0 SARAH LAMPE CHIEF EXECUTIVE OFFICER 40.00 X 0 0 0 WESLEY WILLIAMS PHD CHAIRPERSON 1.00 X X 0 0 0 BRENT BOWMAN TREASURER 1.00 X X 0 0 0 ERIC KINTER SECRETARY 1.00 X X 0 0 0 SHAWN BEALS BOARD MEMBER 1.00 X 0 0 0 KIM BIMESTEFER BOARD MEMBER 1.00 X 0 0 0 DANIEL ANDREW CARNEGIE BOARD MEMBER 1.00 X 0 0 0 NIKO SKIEVASKI BOARD MEMBER 1.00 X 16000 0 0 DARLENE TAD-Y MD BOARD MEMBER 1.00 X 0 0 0 DANIELLE VARDA BOARD MEMBER 1.00 X 0 0 0 159739 0 0 1 true false false 822017 822017 CONTRACT REVENUE 900099 165270 0 0 REGISTRATION FEES 900099 15528 0 0 180798 476 0 476 1003291 180798 0 476 143738 123615 7187 12936 312722 268941 15636 28145 22084 18992 1104 1988 46500 39990 2325 4185 36760 4402 31533 825 25575 0 25575 0 24536 3002 21174 360 20142 15354 2394 2394 11671 495 9084 2092 21071 13671 5691 1709 PROGRAM EXPENSES 448732 424234 14361 10137 OPERATIONAL COSTS 11697 2329 4243 5125 CONSULTING 20582 4834 110 15638 1145810 919859 140417 85534 113619 485480 598212 142148 90000 77325 25249 3332 5623 1718 3905 814405 724865 41586 3364 200000 297500 241586 300864 X 272819 111900 300000 312101 572819 424001 814405 724865 -142519 -6300 1 X false false false X 0 485196 630500 812959 695500 822017 3446172 0 0 485196 630500 812959 695500 822017 3446172 765302 2680870 125 48 28 130 476 807 0 121355 84664 122475 378441 180998 887933 4334912 0.61840 0.58140 X 0 0 0 Pt II Ln 10 Other Income Part II, Line 10 Description: OTHER INCOME 2019: 121355. 2020: 84664. 2021: 122475. 2022: 378441. 2023: 180998. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 5623 1718 3905 3905 1007091 3800 3800 1003291 1003291 1149610 3800 3800 1145810 1145810 false false false false false false false false false RACHEL DIXON 143739 0 0 0 0 0 0 0 0 0 143739 0 0 0 Pt VI, Line 15a THE BOARD DETERMINES PRESIDENT/EXECUTIVE DIRECTOR COMPENSATION BASED ON CURRENT MARKET RATES FOR SIMILAR POSITIONS AND SIMILAR SIZED ORGANIZATIONS. Pt VI, Line 15b THE BOARD DETERMINES PRESIDENT/EXECUTIVE DIRECTOR COMPENSATION BASED ON CURRENT MARKET RATES FOR SIMILAR POSITIONS AND SIMILAR SIZED ORGANIZATIONS. Pt VI, Line 11b THE IRS FORM 990 IS REVIEWED AND APPROVED BY THE PRESIDENT/EXECUTIVE DIRECTOR AND MANAGEMENT PRIOR TO FILING, COPIES OF THE IRS FORM 990 ARE AVAILABLE TO THE BOARD OF DIRECTORS.